Mithra Pharmaceuticals SA
EBR:MITRA.BR
Overview | Financials
Company Name | Mithra Pharmaceuticals SA |
Symbol | MITRA.BR |
Currency | EUR |
Price | 0.216 |
Market Cap | 14,927,414 |
Dividend Yield | 0% |
52-week-range | 0.201 - 1.51 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. David Horn Solomon M.D. |
Website | https://www.mithra.com |
An error occurred while fetching data.
About Mithra Pharmaceuticals SA
Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for estetrol-based
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD